Cargando…

Coping with Stress in Neoplastic Diseases

Introduction: Disease-related stress is a common phenomenon. It also occurs in neoplastic diseases. Since physical and mental health are interrelated, it is important to make sure that treatment covers these two areas. Therefore, it is essential to learn how patients with neoplastic diseases can cop...

Descripción completa

Detalles Bibliográficos
Autores principales: Olejniczak, Dominik, Mularczyk-Tomczewska, Paulina, Klimiuk, Krzysztof, Olearczyk, Agata, Kielan, Aleksandra, Staniszewska, Anna, Osowiecka, Karolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367910/
https://www.ncbi.nlm.nih.gov/pubmed/35955039
http://dx.doi.org/10.3390/ijerph19159675
_version_ 1784765956867751936
author Olejniczak, Dominik
Mularczyk-Tomczewska, Paulina
Klimiuk, Krzysztof
Olearczyk, Agata
Kielan, Aleksandra
Staniszewska, Anna
Osowiecka, Karolina
author_facet Olejniczak, Dominik
Mularczyk-Tomczewska, Paulina
Klimiuk, Krzysztof
Olearczyk, Agata
Kielan, Aleksandra
Staniszewska, Anna
Osowiecka, Karolina
author_sort Olejniczak, Dominik
collection PubMed
description Introduction: Disease-related stress is a common phenomenon. It also occurs in neoplastic diseases. Since physical and mental health are interrelated, it is important to make sure that treatment covers these two areas. Therefore, it is essential to learn how patients with neoplastic diseases can cope with stress. Materials and Methods: The respondents are 306 patients suffering from neoplastic diseases, associated in patient advocacy groups. The method is the Brief-COPE (Coping Orientation to Problems Experienced) questionnaire. Results: The following stress management strategies were most commonly adopted by the patients: acceptance (median 2.25; 25–75% IQR 2.0–3.0), active coping (median 2.0; 25–75% IQR (interquartile range) 1.5–2.0), planning (median 2.0; 25–75% IQR 2.0–2.0), emotional support (median 2.0; 25–75% IQR 1.5–2.0), instrumental support (median 2.0; 25–75% IQR 2.0–2.0), self-distraction (median 2.0; 25–75% IQR 1.5–3.0), and venting (median 2.0; 25–75% IQR 1.5–3.0). A decision to adopt a particular stress management strategy by patients with neoplastic diseases was highly affected by demographic factors (p < 0.05), such as sex, education, age, place of residence and employment. Conclusions: Teaching stress management strategies should be a part of the education process among patients with neoplastic diseases. Before or in the course of treatment, an oncology patient should be educated on the prevention of mental health disorders. The ability to cope with stress is one of the key competences for the course of neoplastic diseases and it can affect the treatment process. Stress management in chronic diseases, including neoplastic diseases, should be approached not only at the level of an individual person but also at the level of the health system as a whole.
format Online
Article
Text
id pubmed-9367910
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93679102022-08-12 Coping with Stress in Neoplastic Diseases Olejniczak, Dominik Mularczyk-Tomczewska, Paulina Klimiuk, Krzysztof Olearczyk, Agata Kielan, Aleksandra Staniszewska, Anna Osowiecka, Karolina Int J Environ Res Public Health Article Introduction: Disease-related stress is a common phenomenon. It also occurs in neoplastic diseases. Since physical and mental health are interrelated, it is important to make sure that treatment covers these two areas. Therefore, it is essential to learn how patients with neoplastic diseases can cope with stress. Materials and Methods: The respondents are 306 patients suffering from neoplastic diseases, associated in patient advocacy groups. The method is the Brief-COPE (Coping Orientation to Problems Experienced) questionnaire. Results: The following stress management strategies were most commonly adopted by the patients: acceptance (median 2.25; 25–75% IQR 2.0–3.0), active coping (median 2.0; 25–75% IQR (interquartile range) 1.5–2.0), planning (median 2.0; 25–75% IQR 2.0–2.0), emotional support (median 2.0; 25–75% IQR 1.5–2.0), instrumental support (median 2.0; 25–75% IQR 2.0–2.0), self-distraction (median 2.0; 25–75% IQR 1.5–3.0), and venting (median 2.0; 25–75% IQR 1.5–3.0). A decision to adopt a particular stress management strategy by patients with neoplastic diseases was highly affected by demographic factors (p < 0.05), such as sex, education, age, place of residence and employment. Conclusions: Teaching stress management strategies should be a part of the education process among patients with neoplastic diseases. Before or in the course of treatment, an oncology patient should be educated on the prevention of mental health disorders. The ability to cope with stress is one of the key competences for the course of neoplastic diseases and it can affect the treatment process. Stress management in chronic diseases, including neoplastic diseases, should be approached not only at the level of an individual person but also at the level of the health system as a whole. MDPI 2022-08-05 /pmc/articles/PMC9367910/ /pubmed/35955039 http://dx.doi.org/10.3390/ijerph19159675 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Olejniczak, Dominik
Mularczyk-Tomczewska, Paulina
Klimiuk, Krzysztof
Olearczyk, Agata
Kielan, Aleksandra
Staniszewska, Anna
Osowiecka, Karolina
Coping with Stress in Neoplastic Diseases
title Coping with Stress in Neoplastic Diseases
title_full Coping with Stress in Neoplastic Diseases
title_fullStr Coping with Stress in Neoplastic Diseases
title_full_unstemmed Coping with Stress in Neoplastic Diseases
title_short Coping with Stress in Neoplastic Diseases
title_sort coping with stress in neoplastic diseases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367910/
https://www.ncbi.nlm.nih.gov/pubmed/35955039
http://dx.doi.org/10.3390/ijerph19159675
work_keys_str_mv AT olejniczakdominik copingwithstressinneoplasticdiseases
AT mularczyktomczewskapaulina copingwithstressinneoplasticdiseases
AT klimiukkrzysztof copingwithstressinneoplasticdiseases
AT olearczykagata copingwithstressinneoplasticdiseases
AT kielanaleksandra copingwithstressinneoplasticdiseases
AT staniszewskaanna copingwithstressinneoplasticdiseases
AT osowieckakarolina copingwithstressinneoplasticdiseases